Daniel S. Goldberger - 31 Mar 2022 Form 4 Insider Report for REPRO MED SYSTEMS INC (KRMD)

Reporting relationship: Director
Issuer ticker: KRMD
Reported as of: 31 Mar 2022
Net transaction value: +$14,984
SEC form: 4
Accepted by SEC: 04 Apr 2022, 17:14:48 UTC
Prior SEC filing: 19 Jan 2022
Next SEC filing: 17 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Karen Fisher- Attorney-in-Fact

Key filing fact

Daniel S. Goldberger filed Form 4 for REPRO MED SYSTEMS INC (KRMD) on 04 Apr 2022.

Key facts

This page summarizes Daniel S. Goldberger's Form 4 filing for REPRO MED SYSTEMS INC (KRMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Apr 2022, 17:14.

Change

Previous filing in this sequence was filed on 19 Jan 2022.
Current net transaction value: +$14,984.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRMD transaction

Common Stock

Award

Transaction value: $14,984
Shares: +5,221
Change %: +4.5%
Price: $2.87
Shares after: 120,334
Date: 31 Mar 2022
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

SEC remarks

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.